These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2455158

  • 1. Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents.
    Louis WJ, McNeil JJ, Anavekar SN, Conway EL, Workman B, Howes LG, Drummer OH, Jarrott B.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S100-3. PubMed ID: 2455158
    [Abstract] [Full Text] [Related]

  • 2. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
    Luther RR, Glassman HN, Sperzel WD, Steinberg FJ, Horton JK, Jordan DC.
    J Hypertens Suppl; 1986 Dec; 4(5):S494-7. PubMed ID: 2883273
    [Abstract] [Full Text] [Related]

  • 3. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS, Hirokawa WT.
    Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
    [Abstract] [Full Text] [Related]

  • 4. Alpha 2-agonist versus alpha 1-antagonist in mild-to-moderate hypertension: comparison of transdermal clonidine and terazosin monotherapies.
    Harris SI, Alvarez C.
    Am J Ther; 1997 Jan; 4(1):9-15. PubMed ID: 10423584
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of alpha 1-blockers in combination therapy for hypertension.
    Zusman RM.
    Int J Clin Pract; 2000 Jan; 54(1):36-40. PubMed ID: 10750258
    [Abstract] [Full Text] [Related]

  • 8. Age-related effects of antihypertensive therapy with alpha-blockers.
    Stokes GS.
    J Cardiovasc Pharmacol; 1988 Jan; 12 Suppl 8():S109-15. PubMed ID: 2469891
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive effects of doxazosin in systemic hypertension and comparison with terazosin.
    Hayduk K, Schneider HT.
    Am J Cardiol; 1987 May 29; 59(14):95G-98G. PubMed ID: 2884860
    [Abstract] [Full Text] [Related]

  • 10. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA.
    J Hypertens Suppl; 1999 Aug 29; 17(3):S15-21. PubMed ID: 10489094
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic applications of drugs acting on alpha-adrenoceptors.
    MacDonald E, Ruskoaho H, Scheinin M, Virtanen R.
    Ann Clin Res; 1988 Aug 29; 20(5):298-310. PubMed ID: 2905875
    [Abstract] [Full Text] [Related]

  • 12. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ, Guo YL, Gu FL.
    J Med; 1998 Aug 29; 29(5-6):289-304. PubMed ID: 10503165
    [Abstract] [Full Text] [Related]

  • 13. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Young RA, Brogden RN.
    Drugs; 1988 May 29; 35(5):525-41. PubMed ID: 2899495
    [Abstract] [Full Text] [Related]

  • 14. Clinical pharmacology and therapeutic role of prazosin and related alpha-adrenoceptor antagonists.
    Reid JL, Vincent J.
    Cardiology; 1986 May 29; 73(3):164-74. PubMed ID: 2872958
    [Abstract] [Full Text] [Related]

  • 15. Review of the use of alpha-adrenoceptor antagonists in hypertension.
    Stokes GS, Marwood JF.
    Methods Find Exp Clin Pharmacol; 1984 Apr 29; 6(4):197-204. PubMed ID: 6146746
    [Abstract] [Full Text] [Related]

  • 16. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N, Benning CM.
    Cancer Res; 2000 Aug 15; 60(16):4550-5. PubMed ID: 10969806
    [Abstract] [Full Text] [Related]

  • 17. Doxazosin, a new alpha-1-antagonist drug, controls hypertension without causing airways obstruction in asthma and COPD.
    Biernacki W, Flenley DC.
    J Hum Hypertens; 1989 Dec 15; 3(6):419-25. PubMed ID: 2575174
    [Abstract] [Full Text] [Related]

  • 18. The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension.
    Warren JB, Dollery CT.
    J Hypertens Suppl; 1988 Dec 15; 6(2):S43-9. PubMed ID: 2906700
    [Abstract] [Full Text] [Related]

  • 19. Terazosin: a new alpha adrenoceptor blocking drug.
    Achari R, Laddu A.
    J Clin Pharmacol; 1992 Jun 15; 32(6):520-3. PubMed ID: 1353083
    [Abstract] [Full Text] [Related]

  • 20. [Central and peripheral alpha-agonist and antagonist drugs in pharmacology and therapy].
    Basile V, Marino A.
    Clin Ter; 1989 Dec 31; 131(6):363-71. PubMed ID: 2576645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.